Drug Shows Promise for Parkinson’s Patients
A preliminary trial on the safety of a drug for use by those with Parkinson’s disease surprised scientists when all five patients in the test showed measurable improvement.
The drug, GDNF, eliminated the periods of immobility that had occurred as much as 20% of the time before treatment and reduced or stopped the involuntary movements common to the disease, said Clive N. Svendsen of the University of Wisconsin Madison. The findings are in the online issue of Nature Medicine.
Also, the senses improved for three patients who had lost the ability to taste or smell.